Voloridge Investment Management
CMD

Voloridge Investment Management’s Cantel Medical Corporation CMD Stock Holding History

Voloridge Investment Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-69,409
Closed -$5.54M – 1867
2021
Q1 		$5.54M Buy
69,409
+35,635
+106% +$2.78M 0.04% 496
2020
Q4 		$2.66M Buy
+33,774
New +$1.98M 0.02% 644
2020
Q3 		– Sell
-8,498
Closed -$376K – 1576
2020
Q2 		$376K Sell
8,498
-9,736
-53% -$363K ﹤0.01% 1087
2020
Q1 		$655K Buy
+18,234
New +$1.04M 0.02% 630
2019
Q2 		– Sell
-14,463
Closed -$967K – 1202
2019
Q1 		$967K Buy
+14,463
New +$1.1M 0.03% 490
2018
Q4 		– Sell
-6,893
Closed -$635K – 517
2018
Q3 		$635K Buy
+6,893
New +$657K 0.01% 242

Voloridge Investment Management's CMD Position: Q2 2021 in Review

Voloridge Investment Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 69,409 shares — an estimated $5.54M sold.

Voloridge Investment Management first reported a position in CMD in Q3 2018 and held it in 6 quarters. The position peaked at $5.54M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Voloridge Investment Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 69,409 Cantel Medical Corporation shares in Q2 2021, an estimated $5.54M.
  • Voloridge Investment Management first reported a position in Cantel Medical Corporation in Q3 2018 and held it in 6 quarters.
  • Voloridge Investment Management's Cantel Medical Corporation position peaked at $5.54M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Voloridge Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.